PCSK9 inhibitor recaticimab for hypercholesterolemia on stable statin dose: a randomized, double-blind, placebo-controlled phase 1b/2 study.
Xu M, Zhu X, Wu J, Zhang Y, Zhao D, Wang X, Ding Y, Cao Y, Li C, Hu W, Sheng J, Luo Z, Zheng Z, Hu J, Liu J, Zhou X, Shen A, Ding X, Zhang Y, Zhao Y, Li Y, Zhong S, An S, Zou J, Yan L.
Xu M, et al. Among authors: zhang y.
BMC Med. 2022 Jan 18;20(1):13. doi: 10.1186/s12916-021-02208-w.
BMC Med. 2022.
PMID: 35039035
Free PMC article.
Clinical Trial.